Focus on Antibodies

Antibody Patent Review: Global Perspectives on Enhancing Biologic Assets Protections

May 17, 2019 9:15am

Karine Crepin

Karine Crepin
VP Head of Biologics Patents
Sanofi (Paris, France)

Thomas Kowalski

Thomas J. Kowalski
Duane Morris LLP

Duane Marks

Duane Marks
Patent Counsel (Biomedicine)
Eli Lilly (Indianapolis, IN)

Casey Thampoe

Immac J. Thampoe (“Casey”)
Assistant General Counsel – IP Portfolio Development
Regeneron Pharmaceuticals Inc. (Tarrytown, NY)

  • Discussing the latest antibody patent case law in the U.S and Europe and interpreting their results
  • Examining the scope and assessment for antibody patent protection in U.S. and Europe
    • Comparing the difference in the meaning of inherent properties
    • Understanding how to avoid issues rising from third party intervention
  • Assessing the interplay between functional and structural features
  • Exploring current prosecution challenges in U.S. and Europe